Search

Search Constraints

You searched for: Author/Creator Christensen, James G.

Search Results

1. Design and evaluation of achiral, non-atropisomeric 4-(aminomethyl)phthalazin-1(2H)-one derivatives as novel PRMT5/MTA inhibitors. (1st October 2022)

2. First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced KRASG12C Solid Tumors (KRYSTAL-1). Issue 23 (10th August 2022)

3. Fragment optimization and elaboration strategies – the discovery of two lead series of PRMT5/MTA inhibitors from five fragment hits. Issue 12 (27th September 2022)

4. Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines. (6th March 2014)

5. Metabolism, excretion and pharmacokinetics of [14C]crizotinib following oral administration to healthy subjects. (January 2015)

6. Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes. Issue 4 (20th December 2018)

7. Synergistic Effect of the γ‐Secretase Inhibitor PF‐03084014 and Docetaxel in Breast Cancer Models. (13th February 2013)